News
Explore market and company news with sources and timestamps.
- Current data
- Each article’s publication time
- Next data
- New data per source
- Expected availability
- No confirmed schedule
Topic
Topics are assigned from article titles and may differ from the publisher’s categories.
Collection is delayed. Showing previously collected news.
[ESMO 2026] 박셀바이오 “CAR-MIL, 동물실험 생존율 100%…J&J 카빅티와 ... (new window)
Other newswww.edaily.co.krKORead supplied summary — [ESMO 2026] 박셀바이오 “CAR-MIL, 동물실험 생존율 100%…J&J 카빅티와 ...
박셀바이오 (323990)가 개발 중인 다발골수종 세포치료제 ‘VCB-1201’이 전임상 동물실험에서 120일간 생존율 100%를 기록한 것으로 확인됐다. 기존 키메라 항원 수용체 T세포(CAR-T) 치료제보다 우수한 항종양 활성과...
Summary supplied by the source. Open the original for the full article.